|
Brian P. Carey
Partner
Boston
Brian Carey's law practice focuses on advising life sciences companies, health care providers and private equity investors on federal legislative and regulatory issues. His work with biotechnology, pharmaceutical and medical device companies includes advice and counsel on legislative aspects of the Medicare prescription drug coverage, Medicare coverage and reimbursement, and food and drug issues. He also represents health care provider clients before the Centers for Medicare & Medicaid Services on National Coverage Decisions, reimbursement under the Hospital Outpatient and Inpatient Prospective Payment Systems and in Medicare Coverage Advisory Committee proceedings.
For a variety of educational institutions and companies, Brian provides legislative guidance on the Elementary and Secondary Education Act, the Higher Education Act, Individuals with Disabilities Education Act, and various other regulatory issues focused on the U.S. Department of Education.
Brian's extensive background in health care policy matters includes serving as a legislative aide to Senator Edward M. Kennedy on the Committee on Labor and Human Resources. In that capacity he worked on health care, food and drug and biotechnology legislation, including the Prescription Drug User Fee Act of 1992 and Dietary Supplement Health and Education Act of 1994. Prior to Foley Hoag Brian was an associate at Sullivan & Cromwell, and he was a judicial law clerk for the Honorable Edward F. Harrington of the United States District Court of Massachusetts
Bars and Court Admissions
Massachusetts
New York
U.S. Court of Appeals, First Circuit
U.S. District Court for the Southern District of New York
U.S. District Court for the District of Massachusetts
SPEECHES AND CONFERENCES
High Country Nuclear Medicine Meeting: "Quality Reporting and Pay for Performance: A View from Congress," March 2007
National Venture Capital Association Conference: "What Early Stage Companies Need to Know about Medicare," Palo Alto, December 2006
Mass Biotech Council's 8th Annual Investor Conference -- MASS Opportunities: "A Biotechnology Investment Conference," November 2006
Mid-America Healthcare Investors Network Meeting:"What Early Stage Life Sciences Companies Need to Know About Medicare Coverage and Reimbursement", November 2006
The 6th Annual Medicare & Medicaid Symposium: "Charting the Course through Medicare Part D," May 2006
Mass MEDIC Conference: "Evidence-Based Medicine - Key Trends and Lessons Learned from CMS," April 2006
The Pinsonault PBM Symposium: "An Inside the Beltway Perspective on Medicare Part D Benefit," March 2006
"The Pinsonault Medicare Part D & Specialty Symposium: Strategic Implications on the Biotechnology Sector of the New Medicare Part D Benefit & Changes in Payment and Coverage for Part B Drugs," November 2005
Mass Biotech Council Law and Policy Committee: "The Era of Medicare Defining, Measuring and Paying for Quality "Coverage with Evidence Development" (CED)," October 2005
Mass Biotech Council Committee Day: "Payment Reforms for Drugs and Biologics Under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003," January 2004
Academy of Molecular Imaging Annual Conference: "Overview of Medicare Coverage and Reimbursement Policy," October 2002
publications
Co-author, "The National Oncologic PET Registry: Expanded Medicare Coverage for PET Under Coverage with Evidence Development," AMERICAN JOURNAL OF ROENTGENOLGY, VOL. 188 NO. 4 (April 2007)
Co-author, "Medicare Coverage of PET for Cervical Cancer," JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, VOL. 3 NO. 1 (January 2006).
| 